Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news Pharmaceutical news
Where Medical Sales Professionals...Click

Home | Contact | Advertise | News | RSS | Jobs 

Home Manager Resources Sales Executive Resources Trainee & Graduate Resources Nurse Resources Medical sales, pharmaceutical sales & healthcare sales jobs

Medical, Pharmaceutical & Healthcare sales jobs

 




Home » News » 02/06 » GlaxoSmithKline drug side effects up after TV programme

GlaxoSmithKline drug side effects up after TV programme

Date published: 14/02/2006

A series of current affairs programmes about GlaxoSmithKline's antidepressant drug Seroxat (paroxetine) were followed by a sudden increase in the number of adverse reactions reported by UK doctors, researchers have shown. Reports to British doctors about the drug rose by 61 per cent after three editions of the BBC's Panorama explored concerns about the drug.

The first of the trio of Panorama programmes was prompted by concerns about paroxetine expressed in 2002 by the US Food and Drug Administration. Some people who had stopped taking the drug seemed to be experiencing severe withdrawal symptoms, and there were reports of a link between paroxetine and suicidal behaviour. Panorama, which is the BBC's flagship current affairs programme, investigated these concerns and broadcast programmes on the subject in October 2002, May 2003 and October 2004.

A research team from Bristol University examined prescribing patterns and adverse drug reports for paroxetine and found the programmes had a significant effect on reports of adverse reactions to the drug. Lead author Dr Richard Martin said: "In the months before and after the three Panorama programmes were aired, adverse reports went up from 8.3 to 13.4 per 100,000 prescriptions. "Our analysis of adverse drug reports made by doctors suggests that negative publicity, particularly the three Panorama programmes, were associated with marked, short-term peaks in reporting."

The five regulatory announcements made about paroxetine in the UK during the same period resulted in a much smaller five per cent increase in reports of adverse reactions, the researchers report in British Journal of Clinical Pharmacology. But the team points out that the effect of the programme was short term, arguing this demonstrates the need for continued efforts to improve the way adverse drug reactions to widely prescribed drugs are monitored.

Panorama, which was first broadcast in 1953, it is the longest-running public affairs television programme in the world. It has won a plethora of awards, including the Mental Health Media Award in 2003 for its first programme on paroxetine.

© Adfero Ltd

Disclaimer

AllAboutMedicalSales excludes any warranty, express or implied, as to the quality, accuracy, timeliness, completeness or fitness for a particular purpose of this briefing. AllAboutMedicalSales will not be liable for any claims, penalties, losses, damages, costs, or expenses arising from the use of or inability to use this briefing or from any unauthorised access to or alteration of the Briefing. AllAboutMedicalSales makes no warranty that the contents of this briefing are compatible with all computer systems and browsers.




Home | Free SMS | Personality Test | Curriculum Vitae | Jobs | Advertise | Pharmaceutical News | NHS News | Pharmaceutical news rss